Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial.
Lancet Oncol
; 24(1): 64-76, 2023 01.
Article
in En
| MEDLINE
| ID: mdl-36528035
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
Multiple Myeloma
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Lancet Oncol
Journal subject:
NEOPLASIAS
Year:
2023
Type:
Article
Affiliation country:
Italy